Stacking Tesamorelin and MOTS-C with Retatrutide: A Complete Protocol Guide
Already on Reta and ready to add compounds? Here's exactly how to stack Tesamorelin and MOTS-C with Retatrutide for maximum fat loss and body recomposition — timing, order, dosing, and what to expect.
PeptIQ Team
Peptide Research & Education
PeptIQ app
Log this Tesamorelin stack in PeptIQ
Track every compound, timing, and dose in one protocol, on web or mobile.
Under 25? Talk to a licensed clinician and get baseline labs before starting anything. Why we say this · Labs checklist
# Stacking Tesamorelin and MOTS-C with Retatrutide: A Complete Protocol Guide
If you're already running Retatrutide and seeing results, the natural question is: what compounds can I add to accelerate body composition changes? Two peptides consistently come up in this conversation — Tesamorelin and MOTS-C.
This guide covers why these specific compounds pair well with Reta, the order to add them, dosing protocols, and what to expect phase by phase.
Why These Three Work Together
Retatrutide, Tesamorelin, and MOTS-C target different pathways that compound on each other:
Retatrutide is a triple-agonist GLP-1/GIP/glucagon receptor agonist. It reduces appetite, slows gastric emptying, and — uniquely among GLP-1s — activates glucagon signaling which directly promotes fat oxidation in the liver. The glucagon component is why many users report better visceral fat reduction vs tirzepatide.
Tesamorelin is a growth hormone-releasing hormone (GHRH) analog. It stimulates your pituitary to release endogenous GH in a natural pulsatile pattern. Clinical trials (particularly the FDA approval studies for HIV lipodystrophy) demonstrated significant visceral fat reduction without the risks of exogenous GH. It's the only FDA-approved compound specifically for visceral fat.
MOTS-C is a mitochondria-derived peptide that activates AMPK — your body's energy sensor. It improves mitochondrial function, enhances fat oxidation during exercise, and has exercise-mimetic properties. For active people, MOTS-C often provides noticeable energy and endurance improvements.
The synergy:
Reta handles appetite suppression and direct glucagon-mediated fat burning
Tesamorelin targets visceral fat specifically through the GH axis
MOTS-C improves cellular energy production and fat utilization
Three different mechanisms, one goal: accelerated body recomposition with preserved (or increased) muscle.
When to Start Stacking
Don't add Tesamorelin or MOTS-C on day one of Reta. Here's why timing matters:
Wait until you're stable on Reta (4-6 weeks minimum). The first month of any GLP-1 involves titration, side effect management, and establishing your baseline response. Adding other compounds during this window makes troubleshooting impossible. If you experience nausea, fatigue, or GI issues, you won't know which compound is responsible.
Good indicators you're ready to stack:
You've found your stable Reta dose (typically 1-3mg weekly)
GLP-1 side effects have subsided or are manageable
Weight loss or body comp changes are proceeding as expected
You want to accelerate visceral fat loss or improve training performance
The Stacking Order: Tesamorelin First
If you're adding both compounds, start with Tesamorelin:
Week 1-2: Add Tesamorelin 1mg daily (evening injection, before bed)
Week 3-4: Increase to 2mg daily if tolerated
Week 5-6: Add MOTS-C 500mcg daily (morning, any time)
Why Tesamorelin First
Synergy with Reta's fat loss mechanisms. Tesamorelin's visceral fat effect compounds directly with Reta's glucagon signaling. You'll see body composition changes faster with this pair than either alone.
Easier to assess. Tesamorelin effects (sleep quality improvement, subtle body recomp, potential water retention) appear within 2-3 weeks. You can confirm it's working before adding MOTS-C.
No overlap with Reta side effects. Tesamorelin side effects (joint stiffness, mild edema) don't overlap with GLP-1 side effects (nausea, fatigue). Clean troubleshooting if something feels off.
When to Add MOTS-C
Add MOTS-C 2-3 weeks after you're stable on Tesamorelin:
Start at 500mcg daily, morning injection (subQ)
Can increase to 1mg daily after 2 weeks if tolerated
Some prefer 5mg 2-3x weekly instead of daily — both protocols work
MOTS-C effects take 2-3 weeks to become noticeable (improved training endurance, steadier energy levels). It's a more subtle compound than Tesamorelin or Reta.
No need to adjust Reta dose when adding Tesamorelin or MOTS-C
Tesamorelin
Starting dose: 1mg daily
Maintenance dose: 2mg daily
Timing: Evening, before bed (aligns with natural GH pulsatility)
Injection: SubQ, abdomen or thigh
Cycle length: 12 weeks on, 4 weeks off (standard)
MOTS-C
Option A (daily): 500mcg-1mg daily, morning
Option B (pulsed): 5mg 2-3x weekly
Timing: Morning preferred (aligns with metabolic activity)
Injection: SubQ, any site
Cycle length: 8-12 weeks on, 4 weeks off (receptor sensitivity consideration)
Daily Schedule Example
Time
Compound
Dose
Notes
Morning
MOTS-C
500mcg subQ
Before breakfast or with first meal
Evening (before bed)
Tesamorelin
2mg subQ
30+ min after last meal
Weekly (any day)
Retatrutide
Per titration
SubQ, same day each week
This schedule keeps compounds separated and aligns with natural physiology (MOTS-C with daytime metabolic activity, Tesamorelin with nighttime GH pulsing).
What to Expect: Timeline
Weeks 1-2 (Tesamorelin only)
Improved sleep quality (deeper, more restorative)
Possible mild water retention or joint stiffness
Subtle recovery improvement between workouts
Weeks 3-4
Sleep benefits continue
Beginning to see body composition shifts (less bloated, more definition)
Appetite stable (Reta handles this)
Weeks 5-6 (add MOTS-C)
Energy levels stabilize or improve
Training endurance increases (especially cardio)
Fat loss may accelerate
Weeks 8-12
Visible visceral fat reduction
Improved muscle definition and separation
Better workout performance and recovery
Body recomposition effects compound
Side Effects and Management
Tesamorelin
Joint stiffness: Temporary, usually subsides by week 3. Stay hydrated, consider magnesium.
Water retention: Mild, GH-related. Usually stabilizes. Not the same as Reta's dose-related retention.
Injection site reactions: Rotate sites, inject at room temperature.
MOTS-C
Mild fatigue days 1-3: Common, transient. MOTS-C affects energy systems before optimizing them.
Injection site discomfort: Minimal. SubQ technique matters.
Rare GI effects: Less common than BPC-157 GI sensitivity.
Combined Stack
Monitor for cumulative water retention (Reta + Tesamorelin both can cause this)
Track subjective energy (MOTS-C should improve this after initial adjustment)
If something feels off, don't adjust everything — pause one compound and reassess
Frequently Asked Questions
Q: Can I start Tesamorelin and MOTS-C at the same time?
A: You can, but I don't recommend it. Starting one at a time (2-3 weeks apart) gives you clean data on what each compound contributes. If you experience side effects, you'll know which compound to adjust.
Q: Do I need to increase my Reta dose when adding these compounds?
A: No. Your Reta titration should be based on appetite suppression and side effect tolerance, not on what else you're stacking. Most people stabilize at 1-3mg weekly regardless of additional compounds.
Q: What if I can only afford one compound?
A: Tesamorelin if visceral fat is your primary concern. MOTS-C if training performance and energy are the priority. If budget allows, Tesamorelin has a stronger body composition effect for most users.
Q: How long should I run this stack?
A: 12 weeks is a reasonable cycle length. After 12 weeks, cycle off Tesamorelin for 4 weeks (standard protocol), and you can choose to continue or pause MOTS-C. Many people run 2-3 full cycles per year.
Q: What about Ipamorelin instead of Tesamorelin?
A: CJC-1295/Ipamorelin is a solid alternative GH secretagogue stack, but Tesamorelin has stronger clinical evidence specifically for visceral fat. Ipamorelin tends to be cheaper and more available. If budget is a constraint, CJC+Ipa is a reasonable substitute.
Q: Will this stack help me build muscle?
A: Indirectly. Tesamorelin supports GH-mediated muscle protein synthesis. MOTS-C improves workout capacity. Reta can reduce muscle catabolism through improved metabolic signaling. But for significant muscle building, you still need progressive overload training and adequate protein (1.5-2g per kg bodyweight).
Q: Where do I source these compounds?
A: PeptIQ does not sell peptides and does not recommend vendors. Talk with a licensed healthcare provider. This is educational only — not medical advice and not a prescription.
---
Track Your Full Protocol
Running Reta + Tesamorelin + MOTS-C with different frequencies and timing? PeptIQ is built for exactly this — log doses, track subjective response, and see what's actually moving the needle.
Is this multi-peptide education guide medical advice?
No. PeptIQ publishes educational summaries and tracking tools. Talk with a licensed clinician about whether any therapy is appropriate for you.
Can I log what I read here in the PeptIQ app?
Yes. Use PeptIQ on iOS, Android, or the web to save notes, vials, and check-ins. Availability follows your App Store or Google Play region (including the US, Canada, and Australia).
Where should I go for GLP-1 telehealth questions?
If you are comparing licensed tirzepatide or semaglutide paths, see our GLP-1 telehealth partner disclosure on eligible pages. PeptIQ may earn a referral fee; offers use code PEPTIQ100 where noted.
